【摘 要】
：
The aim of this study was to analyze outcomes in adult patients with early stage systemic anaplastic large-cell lymphoma (ALCL) treated with doxorubicin-based chemotherapy and radiotherapy.Forty-six a
【机 构】
：
Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Pe
论文部分内容阅读
The aim of this study was to analyze outcomes in adult patients with early stage systemic anaplastic large-cell lymphoma (ALCL) treated with doxorubicin-based chemotherapy and radiotherapy.Forty-six adult patients with early stage systemic ALCL received chemotherapy followed by radiotherapy.All patients except two received chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or a CHOP-like regimen.Twenty patients had stage Ⅰ disease, and 26 patients had stage Ⅱ disease.The 5-yr overall survival (OS), progression-free survival (PFS), and local control rates for all patients were 84.4%, 63.6%, and 90.8%, respectively.The 5-yr OS and PFS rates were 95.0% and 77.4% for Ann Arbor stage Ⅰ disease, and 75.1% and 51.7% for stage Ⅱ disease, respectively.Lymph node involvement was the main pattern of disease progression or relapse for these patients.Adult patients with early stage systemic ALCL treated with doxorubicin-based chemotherapy and radiotherapy had a favorable prognosis.
其他文献
目的:回顾性分析乳腺癌脑转移再程放疗的疗效和影响预后的相关因素.方法:收集36例行再程放疗的乳腺癌脑转移患者,按L-Q模式计算等效生物剂量,计算总生存时间、中位局部控制时间,评估疗效、记录放疗不良反应.结果:全组患者中位年龄51.2岁(32.2-64.8岁),再程放疗后中位生存时间为9.1个月(1.3-56.8个月),6个月、12个月的总生存率分别为71.1％和33.9％,局部控制率分别为72.3
目的:探讨乳腺癌脑转移患者(Breast cancer brain metastases BCBM)预后生存的影响因素.方法:回顾分析2000年1月至2013年8月军事医学科学院附属医院收治的342例乳腺癌脑转移患者的临床病理资料、治疗措施等因素对BCBM患者生存期的影响.结果:全组患者脑转移的中位年龄47.8岁(25.3-79.9岁),从确诊乳腺癌到发生脑转移的中位时间为40.5个月(0-264
Introduction: To compare definitive intensity-modulated radiotherapy (IMRT) with definitive 2D radiotherapy (2D-RT) in cervical esophageal squamous cell carcinoma (CESCC).Methods: A total of 101 patie
Background The role of adjuvant radiotherapy (RT) for patients with stage Ⅲ thymoma after complete resection is not definite.Some authors have advocated postoperative RT after complete tumor resection
This was a hospital-based, nationwide retrospective epidemiologic study, from 1999 to 2008 in China, of patients with breast cancer.A total of 1009 (27%) of the 3732 randomly selected patients receive
目的:观察康莱特注射液(Kanglaite injection,KLT)联合体部伽玛刀对局部晚期胰腺癌的治疗效果.方法:55例局部晚期胰腺癌患者,随机分为两组,研究组28例:采用体部伽玛刀治疗,PTV覆盖95％以上临床靶体积(Clinical target volume,CTV),等剂量曲线为50％～60％.肿瘤≤5cm的单次周边剂量3.6-4.5 Gy,肿瘤＞5cm的单次周边剂量3.0～4.0
The purposes of this study are to evaluate prognosis in patients with locoregionally recurrent extranodal nasal-type NK/T cell lymphoma (NKTCL) and to determine the value of salvage radiotherapy.Forty
Patients with early stage peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS) have a poor prognosis, and data on early stage PTCL-NOS are lacking.This study describes the outcome in such pa
The dosimetric and clinical outcomes of intensity modulated radiation therapy for primary mediastinal large B-cell lymphoma after chemotherapy have not been reported previously, to our knowledge.This